Alzheimer's disease is a progressive, irreversible neurodegenerative disease impacting
cognition, function, and behavior. Alzheimer's disease progresses along a continuum from …

Alzheimer's disease is the leading cause of dementia. However, neither Alzheimer's disease
nor Alzheimer's dementia are an inevitable consequence of aging. This review provides an …

This article describes the public health impact of Alzheimer's disease (AD), including
incidence and prevalence, mortality and morbidity, costs of care, and the overall impact on …

The reconceptualization of Alzheimer's disease (AD) as a clinical and biological construct
has facilitated the development of biomarker-guided, pathway-based targeted therapies …

Objective: To compare the accuracy of Mini-Mental State Examination (MMSE) and of the
Montreal Cognitive Assessment (MoCA) in tracking mild cognitive impairment (MCI) and …

Alzheimer's disease and related dementias (ADRDs) are a global crisis facing the aging
population and society as a whole. With the numbers of people with ADRDs predicted to rise …

The critical role of primary care clinicians (PCCs) in Alzheimer's disease (AD) prevention,
diagnosis and management must evolve as new treatment paradigms and disease …

Importance The US aging population is rapidly becoming more racially and ethnically
diverse. Early diagnosis of dementia is a health care priority. Objective To examine the …

In the 12 years since the publication of the first Consensus Paper of the WFSBP on
biomarkers of neurodegenerative dementias, enormous advancement has taken place in …

This article describes the public health impact of Alzheimer's disease (AD), including
incidence and prevalence, mortality and morbidity, use and costs of care, and the overall …